Filed in archive
Diagnostics, Methodologies and Instrumentation
, Drugs, Vaccines and Therapeutics
, Genomics, Proteomics and Bioinformatics
by ruth on November 29, 2006

"We've developed a yeast model system in which A-beta small aggregate formation can be detected," said Liebman. "The system employs a fusion of the human A-beta peptide to a functional yeast protein, called a reporter protein, which is only active in allowing cells to grow on test media if the fusion does not form aggregates."
[The author] said the yeast model system can be used to develop a high throughput assay to screen small molecules to find those that inhibit the A-beta dependent aggregation. "We'll screen a library of drugs and compounds, looking for ones that allow our yeast with the reporter protein to grow."
Preventing the formation and accumulation of these aggregates may thus prevent the progression of AD. The study has been published online in BMC Biology.
[Souce: University of Illinois, Photo: AβMRF causes nonsense suppression in yeast, click here for larger image and full caption]
Tags:
drug+discovery
proteomics
genomics
Alzheimer
alzheimers+disease
biotech
yeast+model
alzheimer+diseas
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/44146
Mr Wong
Vote for Yeast Model As Tool For Alzheimer's Disease Drug Discovery:
|
Rating: 7.60 out of 5 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







